CIRCULOGENE Announces Issuance of U.S. Patent for Method of Preparing Cell-Free Nucleic Acid Molecules by In Situ Amplification
Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification, enabling “in situ” genetic manipulation of biofluid samples. BIRMINGHAM, Ala. – CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine [...]
CIRCULOGENE Appoints Stephen Unger Chief Financial Officer
BIRMINGHAM, Ala. – CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine through rapid delivery of actionable results, announced today that Stephen Unger has joined the company as Chief Financial Officer. Mr. Unger has more [...]
Free Webinar: Drawing NGS Plasma at Time of Lung Biopsy
CIRCULOGENE Free Webinar Drawing NGS Plasma at Time of Lung Biopsy, To Do or Not To Do Jun 3, 2020 7:00PM Eastern Time Please join us for this free educational webinar where our panel [...]